Cliff Feltham

Home Page

AstraZeneca awaits US drug decision

By Cliff FelthamDaily Mail
13 Apr 2012
Home Page

Hopes of 'blockbuster' at Phytopharm

By Cliff Feltham
12 Apr 2012
Home Page

Fighting back from a yellow card

By Cliff Feltham
12 Apr 2012
Home Page

Man Utd soothes dividend fears

By Cliff Feltham
12 Apr 2012
Home Page

Carnival fires a broadside

By Cliff Feltham
22 Jan 2002
Home Page

City widens search for safe haven

By Cliff Feltham
12 Apr 2012
Home Page

Promoters at GHW face fraud probe

By Cliff Feltham
12 Apr 2012
Home Page

IBT has no antidote for turbulence

By Cliff Feltham
6 Nov 2001
Home Page

Drug scandal batters German giant

By Cliff Feltham
15 Nov 2001
Home Page

Assets row one in Eye for publisher

By Cliff Feltham
14 Dec 2001
Home Page

Rail 'strategy' could cost extra £870m

By Cliff Feltham
15 Jan 2002
Home Page

Reed hit by 'baseless' scam claims

By Richard InderCliff Feltham
12 Apr 2012
Home Page

Pressure builds for Enic break-up

By Cliff Feltham
12 Apr 2012
Home Page

City widens search for safe haven

By Cliff Feltham
12 Apr 2012
Home Page

Elan probe as shares crash

By Cliff Feltham
5 Feb 2002
Home Page

Dresdner casts doubt over AZ drug

By Cliff Feltham
12 Apr 2012
Home Page

Two cheers for AstraZeneca

By Cliff Feltham
12 Apr 2012
Home Page

Cox punters urged to revolt

By Cliff Feltham
12 Apr 2012
Home Page

Share-buying bosses raise hopes

By Cliff Feltham
12 Apr 2012
Home Page

Carnival fires a broadside

By Cliff Feltham
22 Jan 2002
Home Page

Dresdner casts doubt over AZ drug

By Cliff Feltham
12 Apr 2012
1...456